Prohibited or Enforcement-Action Peptides Melanotan I/II Banned due to melanoma and cardiovascular risk DSIP and Epitalon Unapproved new drug status with FDA warning letters (FDA, 2024) Clinics advertising or selling unapproved peptides for therapeutic use risk FDA and FTC enforcement
September 2021
For tendon models, BPC-157 is better documented
Because CJC-1295 acts upstream of growth hormone, its safety profile is tied to two overlapping issues: Peptide-specific effects , such as injection-site reactions or transient flushing GH/IGF-1-axis effects , such as fluid retention, joint discomfort, changes in glucose handling, or other effects associated with elevated growth hormone signaling The safety discussion is also complicated by naming
From decoding health trends and interviewing doctors to testing fitness routines herself, Tavishi always approaches content with one filter: Will this help someone make a better decision today? Subject expertise With 9+ years tracking Indias health conversations, Tavishi knows the gap between clinical advice and daily life